- Cat. No.
- A16868
MRS1706
MRS1706 is a selective adenosine A2B receptor inverse agonist with Ki values of 1.39, 157, 112, and 230 nM for human A2B, A1, A2A, and A3 receptors, respectively.
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Adenosine receptor agonists and antagonists target A1, A2A, A2B and A3, the four G protein-coupled adenosine receptors. The International Union of Pharmacology (IUPHAR) set out this nomenclature in 2001. A1 and A3 receptors usually inhibit adenylyl cyclase, while A2A and A2B receptors stimulate it. In 2008 the human A2A receptor was crystallized bound to an antagonist at 2.6 Å resolution. Ligands in this category include the A2A agonist CGS 21680 HCl Hydrate, the A2A antagonist istradefylline and the A3 agonist IB-MECA. Xanthines such as theophylline block several subtypes, and 5-Iodotubercidin inhibits adenosine kinase, which phosphorylates adenosine.
MRS1706 is a selective adenosine A2B receptor inverse agonist with Ki values of 1.39, 157, 112, and 230 nM for human A2B, A1, A2A, and A3 receptors, respectively.
Synonyms: KW-6356
Sipagladenant is an orally active inverse agonist of the adenosine A2A receptor. It is primarily utilized in research related to frontal lobe dysfunction, offering insights into the modulation of adenosine signaling pathways. This compound may be useful in elucidating the role of A2A receptors in various neurological conditions.